FeliLeish: An Update on Feline Leishmaniosis and Factors Associated with Infection in Different Feline Populations from Italy
Pathogens · 14.11.2023 · 12 (11) · 1351
DOI: 10.3390/pathogens12111351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 14.11.2023. Verfasst von Eva Spada und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Veterinaria e Scienze Animali (DIVAS), Università degli Studi di Milano, Via dell'Università 6, 26900 Lodi, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Feline leishmaniosis is a worldwide infection caused by the parasite of the genus Leishmania transmitted by sandflies. Based on the complexity of epidemiology and diagnosis of this infection, the role of cats in the epidemiology and clinical impact of disease is still under debate. By using serological and molecular methods, this study aimed to update the epidemiology of the infection in different feline populations from various areas of Italy and to study factors associated with the infection. Of 1490 cats tested, 124 (8.3%, 95% CI 6.9–9.9) were infected, 96 had only specific L. infantum IgG, 18 were only positive for parasite DNA and 10 were both IFAT and qPCR positive. Risk factors for infection were sampling in the winter season (OR = 3.2, 95% CI 2.2–4.8), originating from the Sicily region (OR = 2.0, 95% CI 1.3–3.0), male gender (OR = 1.8, 95% CI 1.1–3.2), outdoor lifestyle (OR = 2.3, 95% CI 0.9–5.6) and seropositivity for FIV antibodies (OR = 2.2, 95% CI 1.2–4.2), while sampling in the spring (OR = 0.5, 95% CI 0.3–0.7) and summer (OR = 0.3, 95% CI 0.1–0.7), and originating from the Lazio region (OR = 0.1, 95% CI 0.05–0.4) were protective factors for infection. In endemic areas, Leishmania infection should be investigated by using both serological and molecular methods and cats should be protected from sandfly bites, particularly if they are FIV infected.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di Medicina Veterinaria e Scienze Animali (DIVAS), Università degli Studi di Milano, Via dell'Università 6, 26900 Lodi, Italy.
- Centro di Referenza Nazionale per le Leishmaniosi (C.Re.Na.L), Istituto Zooprofilattico Sperimentale (IZS) della Sicilia A. Mirri, Via G. Marinuzzi 3, 90129 Palermo, Italy.
- Department of Veterinary Sciences, University of Messina, Polo SS. Annunziata, 98122 Messina, Italy.
- Dipartimento di Prevenzione UOC Sanità Animale, Igiene degli Allevamenti e delle Produzioni Zootecniche, ASL Latina, 04100 Latina, Italy.
ORCID-Profile: Eva Spada, Germano Castelli, Federica Bruno, Francesco La Russa, Vito Biondi, Antonella Migliazzo, Aurora Rossi, Roberta Perego, Daniela Proverbio
Förderung
- Ministero della Salute
Zitieren
APA
Spada, E., Castelli, G., Bruno, F., Vitale, F., La Russa, F., Biondi, V., Accettulli, S., Migliazzo, A., Rossi, A., Perego, R., Baggiani, L., & Proverbio, D. (2023). FeliLeish: An Update on Feline Leishmaniosis and Factors Associated with Infection in Different Feline Populations from Italy. Pathogens, 12(11), 1351. https://doi.org/10.3390/pathogens12111351
Vancouver
Spada E, Castelli G, Bruno F, Vitale F, La Russa F, Biondi V, et al. FeliLeish: An Update on Feline Leishmaniosis and Factors Associated with Infection in Different Feline Populations from Italy. Pathogens. 2023;12(11):1351. doi:10.3390/pathogens12111351
BibTeX
@article{Spada2023,
author = {Spada, Eva and Castelli, Germano and Bruno, Federica and Vitale, Fabrizio and La Russa, Francesco and Biondi, Vito and Accettulli, Sara and Migliazzo, Antonella and Rossi, Aurora and Perego, Roberta and Baggiani, Luciana and Proverbio, Daniela},
title = {FeliLeish: An Update on Feline Leishmaniosis and Factors Associated with Infection in Different Feline Populations from Italy},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {11},
pages = {1351},
doi = {10.3390/pathogens12111351}
}
EUVIMED